Satellos Bioscience Statistics
Total Valuation
MSLE has a market cap or net worth of $201.88 million. The enterprise value is $138.57 million.
| Market Cap | 201.88M |
| Enterprise Value | 138.57M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MSLE has 21.22 million shares outstanding. The number of shares has increased by 46.32% in one year.
| Current Share Class | 21.22M |
| Shares Outstanding | 21.22M |
| Shares Change (YoY) | +46.32% |
| Shares Change (QoQ) | +13.00% |
| Owned by Insiders (%) | 6.94% |
| Owned by Institutions (%) | 41.63% |
| Float | 18.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.37 |
| P/TBV Ratio | 3.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.22
| Current Ratio | 11.22 |
| Quick Ratio | 10.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.45% and return on invested capital (ROIC) is -45.57%.
| Return on Equity (ROE) | -70.45% |
| Return on Assets (ROA) | -41.89% |
| Return on Invested Capital (ROIC) | -45.57% |
| Return on Capital Employed (ROCE) | -59.79% |
| Weighted Average Cost of Capital (WACC) | 10.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.65M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MSLE has paid $154,000 in taxes.
| Income Tax | 154,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.17% in the last 52 weeks. The beta is 1.14, so MSLE's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +64.17% |
| 50-Day Moving Average | 9.47 |
| 200-Day Moving Average | 8.22 |
| Relative Strength Index (RSI) | 54.23 |
| Average Volume (20 Days) | 26,754 |
Short Selling Information
The latest short interest is 89,063, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 89,063 |
| Short Previous Month | 91,665 |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 3.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | -9.48M |
| Operating Income | -35.82M |
| Pretax Income | -34.46M |
| Net Income | -34.61M |
| EBITDA | -35.82M |
| EBIT | -35.82M |
| Earnings Per Share (EPS) | -$1.99 |
Balance Sheet
The company has $61.84 million in cash and no debt, with a net cash position of $61.84 million or $2.91 per share.
| Cash & Cash Equivalents | 61.84M |
| Total Debt | n/a |
| Net Cash | 61.84M |
| Net Cash Per Share | $2.91 |
| Equity (Book Value) | 59.91M |
| Book Value Per Share | 2.87 |
| Working Capital | 59.90M |
Cash Flow
In the last 12 months, operating cash flow was -$29.00 million and capital expenditures -$7,000, giving a free cash flow of -$29.01 million.
| Operating Cash Flow | -29.00M |
| Capital Expenditures | -7,000 |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -29.01M |
| FCF Per Share | -$1.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MSLE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.32% |
| Shareholder Yield | -46.32% |
| Earnings Yield | -17.14% |
| FCF Yield | -14.37% |
Analyst Forecast
The average price target for MSLE is $26.25, which is 168.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.25 |
| Price Target Difference | 168.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 30, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 30, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |